CALLIDUS BIOPHARMA
Callidus Biopharma is a drug discovery company focused on best-in-class enzyme replacement therapies (ERTs) for lysosomal storage disorders (LSDs). Callidus’ novel technology platform is based on attaching a form of the naturally occurring Insulin-like Growth Factor (IGF-2) to enhance the targeting of therapeutic enzymes to the relevant cells in the body. The company’s therapeutics offer the potential to significantly reduce the amount of drug that needs to be infused, which translates t... o patient and medical benefits of better efficacy, shorter infusion times, reduced immunogenicity, and greater convenience. Our lead program is for Pompe Disease but we are also applying our IGF2 technology to other LSDs to improve drug targeting and efficacy. We have also created a more stable enzyme which has the potential to be a superior ERT for Gaucher Disease.
CALLIDUS BIOPHARMA
Industry:
Biotechnology Health Care Therapeutics
Founded:
2010-01-01
Address:
Doylestown, Pennsylvania, United States
Country:
United States
Website Url:
http://www.callidusbiopharma.com
Total Employee:
1+
Status:
Active
Contact:
215-434-7482
Email Addresses:
[email protected]
Total Funding:
6.21 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads Google Adsense For Domains GoDaddy CDN
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.callidusbiopharma.com
Unable to get host informations!!!
More informations about "Callidus Biopharma"
Callidus Biopharma - Crunchbase Company Profile & Funding
Callidus Biopharma is a drug discovery company focused on best-in-class enzyme replacement therapies (ERTs) for lysosomal storage disorders (LSDs). Callidus’ novel technology platform …See details»
Callidus Biopharma Company Profile 2024: Valuation, …
Callidus Biopharma General Information Description. Developer of enzyme-replacement therapies for lysosomal-storage disorders. The company is focused on drug discovery, using a novel technology platform that attaches a form of …See details»
Callidus Biopharma - Products, Competitors, Financials, Employees ...
Callidus Biopharma is a development-stage biotechnology company focused on developing superior drugs for rare and ultra-rare diseases. Use the CB Insights Platform to explore …See details»
Callidus Biopharma - Contacts, Employees, Board Members
Organization. Callidus Biopharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. …See details»
Amicus Therapeutics acquires Callidus Biopharma, announces …
Nov 20, 2013 Amicus Therapeutics (FOLD) announced a strengthening of its biologics business strategy. Amicus has acquired Callidus Biopharma, a privately-held biologics company …See details»
Amicus Therapeutics acquires Callidus Biopharma | Reuters
Nov 20, 2013 Amicus Therapeutics Inc : * Amicus has acquired Callidus Biopharma * Under deal terms, Callidus Shareholders will get $15 million in shares of coSee details»
Callidus Biopharma - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . May 14, 2013: Series A - …See details»
Callidus Biopharma - Contact Details and Employee Directory
Explore Callidus Biopharma at (callidusbiopharma.com) based in Doylestown, Pennsylvania, United States. Discover its industry, revenue, and key employees. Find data for similar …See details»
Callidus Biopharma, Inc.:Financial,Market Cap,Revenue & Financial ...
Discovery Company profile page for Callidus Biopharma, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Amicus Therapeutics Strengthens Biologics Business Strategy / …
Nov 20, 2013 Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, today announced a broad strengthening of …See details»
Cuong Viet Do - BIVI | BioVie Inc. - Wall Street Journal
Founder of M6P Therapeutics, Perceptivus LLC, Identifor, Inc. and Callidus Biopharma, Inc., Cuong Viet Do is an entrepreneur and businessperson who has been at the helm of 6 different …See details»
Biologics CDMO Market Size & Share Analysis - Mordor Intelligence
The biologics contract development and manufacturing organization (CDMO) market is segmented by type (Mammalian and Non-Mammalian (Microbial)), by product type (biologics …See details»
Callidus Biopharma - Updates, News, Events, Signals & Triggers
Callidus Biopharma is a drug discovery company developing enzyme replacement therapies for lysosomal storage disorders.See details»
Top 21 Leading Pharmaceutical Contract Manufacturing …
CordenPharma is a full-service Contract Development & Manufacturing Organization (CDMO) that produces APIs, Excipients, Drug Products, and Packaging Services. They translate complex …See details»
Famous Physicians from India | List of Top Indian Physicians - Ranker
Jul 3, 2024 He was elected as the chairman of the World Health Organization (WHO) Executive Board in 1949 and 1950, was Vice-President of the Eighth World Health Assembly in 1955 and …See details»
STEERLife & Callidus Research Laboratories Forge Strategic …
13 Nov 2024; Admin; News Article; STEERLife & Callidus Research Laboratories Forge Strategic Partnership. STEERLife & Callidus Research Laboratories forge strategic partnership to …See details»
Building a “Best Practice” Commercial Organization in Biopharma
We interviewed dozens of biopharma leaders on the critical success factors for building a Best Practice commercial organization. This report shares what we learned.See details»
Amicus Therapeutics - Funding, Financials, Valuation & Investors
Which types of acquisition does this organization make most frequently? Show . Acquiree Name . Announced Date . Price . Transaction Name . Celenex . Sep 20, 2018: $452M: Celenex …See details»
STEERLife and Callidus Research Laboratories Forge Strategic ...
Nov 12, 2024 STEERLife, a pioneer in pharmaceutical development technologies, and Callidus Research Laboratories, a formulation development services company with a wealth of …See details»
5 Predictions for the Biopharma and Biotech Industries in 2025
Biopharmaceuticals make up a significant portion of the pharmaceutical market, and as of 2024, the biopharma market size was estimated to be over US$400 billion with a projected …See details»